WO2009048494A1 - Method of chemical treatment of porous silicon surfaces - Google Patents

Method of chemical treatment of porous silicon surfaces Download PDF

Info

Publication number
WO2009048494A1
WO2009048494A1 PCT/US2008/009214 US2008009214W WO2009048494A1 WO 2009048494 A1 WO2009048494 A1 WO 2009048494A1 US 2008009214 W US2008009214 W US 2008009214W WO 2009048494 A1 WO2009048494 A1 WO 2009048494A1
Authority
WO
WIPO (PCT)
Prior art keywords
porous silicon
silane
binding
silica
polyethylene glycol
Prior art date
Application number
PCT/US2008/009214
Other languages
English (en)
French (fr)
Inventor
John Lawrence Ervin
Hus Tigli
Mark Kennedy
Original Assignee
Trex Enterprises Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trex Enterprises Corporation filed Critical Trex Enterprises Corporation
Priority to EP08794883A priority Critical patent/EP2185480A4/de
Publication of WO2009048494A1 publication Critical patent/WO2009048494A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Definitions

  • This invention relates to methods for porous to porous silicon and to method for preparing it for bio-molecular interaction studies.
  • An optical biosensor is an optical sensor that incorporates a biological sensing element.
  • optical biosensors have become widely used for sensitive molecular binding measurements.
  • the targets When using labels to monitor these interactions a fluorescent, colorimetric or some other signal is generated by an additional molecule or moiety that is attached to the target or receptor which gives a signal when the interaction takes place.
  • This so called label (or tag) is present only to detect the interaction and is not part of the interaction of interest per se.
  • the receptor and target binding are monitored directly using untagged biomolecules.
  • a variety of technologies exist in the art to detect binding without labels including surface plasmon resonance (SPR) and white light interferometery using porous silicon.
  • SPR surface plasmon resonance
  • instrument architectures which can used. These include plate readers and flow cells. In the case of plate readers a well plate (or micro well plate or micro titer plate) is used to house the biochips and fluids which are used for the label free binding studies. This allows for parallel analyses of several types of data. Alternatively flow cells house biochips in, typically, a microfluidic cell which routes fluid over the region of the biochip where the binding interaction takes place.
  • SPR surface plasmon resonance
  • a resonant mirror system also relies on changes in a penetrating evanescent wave.
  • This system is similar to SPR and, like it, binding reactions between receptors and analytes in a region extremely close to the back side of a special mirror (referred to as a resonant mirror) can be analyzed by examining light reflected when a laser beam directed at the mirror is repeatedly swept through an arc of specific angles.
  • resonant mirror systems are expensive and impractical for many applications.
  • U.S. Patent No. 6,248,539 discloses techniques for making porous silicon and an optical resonance technique that utilizes a very thin porous silicon layer within which binding reactions between ligands and analytes take place.
  • the association and disassociation of molecular interactions affects the index of refraction within the thin porous silicon layer.
  • Light reflected from the thin film produces interference patterns that can be monitored with a CCD detector array. The extent of binding can be determined from change in the spectral pattern.
  • Kinetic binding measurements involve the measurement of rates of association (molecular binding) and disassociation.
  • Analyte molecules are introduced to ligand molecules producing binding and disassociation interactions between the analyte molecules and the ligand molecules.
  • Association occurs at a characteristic rate [A][BJk 0n that depends on the strength of the binding interaction Ic 0n and the ligand topologies, as well as the concentrations [A] and [B] of the analyte molecules A and ligand molecules B, respectively.
  • Binding events are usually followed by a disassociation event, occurring at a characteristic rate [A][B]koff that also depends on the strength of the binding interaction.
  • optical biosensors have been used as an alternative to conventional separations-based instrumentation and other methods.
  • Most separations-based techniques have typically included 1) liquid chromatography, flow-through techniques involving immobilization of capture molecules on packed beads that allow for the separation of target molecules from a solution and subsequent elution under different chemical or other conditions to enable detection; 2) electrophoresis, a separations technique in which molecules are detected based on their charge-to-mass ratio; and 3) immunoassays, separations based on the immune response of antigens to antibodies.
  • separations methods involve a variety of detection techniques, including ultraviolet absorbance, fluorescence and even mass spectrometry.
  • the format also lends itself to measure of concentration and for non-quantitative on/off detection assays.
  • porous silicon biochips are fabricated in the form of a Fabry-Perot cavity where changes in the white light interference spectrum are used to deduce the time course of the biomolecular interaction.
  • This porous silicon biochip is ideally suited for use with the non-invasive, non-destructive, label free white light probe.
  • porous silicon surface would be inappropriate for such biochips for three reasons. First, the porous silicon surface is chemically unstable. That is it degrades under the buffer conditions typically used for biomolecular interaction studies. Second, it is difficult to immobilize the variety of receptors the researcher would want to study on the as formed porous silicon surface.
  • targets and/or receptors could non-specif ⁇ cally bind to the surface, even if the interaction the research would like to study, are not present.
  • This last point, so called non-specific binding (NSB) is of particular concern when designing appropriate surface coverages for biosensor chips.
  • NSS non-specific binding
  • biomolecular interactions In general what one wants to study in biomolecular interactions is the specific binding of one biomolecular to another molecule (which may or may not be a biomolecule). Any interaction which binds a molecule to the surface generates a signal. That is, the biochip readout instrument cannot generally distinguish between a specific binding event (between target and receptor, which is what the researcher wants to study) and between target and surface. A proper biochip surface coverage must minimize this later interaction.
  • the present invention provides a method which renders the 3D surface of the insides of the pores of porous silicon biochip appropriate for conducting studies on biomolecule interactions without labels.
  • the method includes a first step in which an as prepared Si-H surface is converted to a silica surface. This silica surface is then silanized in a process that coats the surfaces of the pores with silane.
  • the silane coated surfaces are then coated with one of a variety of intermediate moieties for the purpose of minimizing non specific binding and to allow for easy immobilization of receptors.
  • a preferred moiety are polymers cut from polyethylene glycol (PEG).
  • PEG polyethylene glycol
  • the PEG molecules are of a variety of lengths between 4 and 60 monomer units.
  • FIG. IA is a general description of the present invention.
  • FIGS. IB and 1C are two preferred embodiments of the present invention.
  • FIG. 2 shows an example of a silanizing reagent (GOPTS).
  • FIG. 3 shows the reaction of GOPTS with the Silica surface.
  • FIG. 4 shows how the thickness of the GOPTS layer plateaus after a certain number of
  • FIG. 5 shows an example hydrophilic reagent polyethylene glycol (PEG).
  • FIG. 6 shows the reaction of hetero bifunctional PEG with the silanized poSi chip
  • FIG. 7 shows the concept of variegated PEG length to increase surface density
  • FIG. 8 shows the preparation of an benzaldehyde surface using thiol chemistry
  • FIG. 9 shows a scheme for single point protein attachment to a surface using ex situ cross linking.
  • a preferred embodiment of the present invention is a method for preparing porous silicon chips for use in a biosensor described in parent patent applications Serial No. 11/180,349 filed 7/13/2005, Serial No. 10/631,592 filed 7/30/2003 and Serial No. 10/616,251 filed
  • porous silicon biochips are fabricated in the form of a Fabry-Perot cavity where changes in the white light interference spectrum are used to deduce the time course of the biomolecular interaction.
  • This porous silicon biochip is ideally suited for use with the non-invasive, non-destructive, label free white light probe.
  • porous silicon surface would be inappropriate for such biochips for three reasons. First, the porous silicon surface is chemically unstable. That is it degrades under the buffer conditions typically used for bio-molecular interaction studies. Second, it is difficult to immobilize the variety of receptors the researcher would want to study on the as formed porous silicon surface.
  • targets and/or receptors could non-specifically bind to the surface, even if the interaction the research would like to study, are not present.
  • This last point, so called non-specific binding is of particular concern when designing appropriate surface coverages for biosensor chips.
  • bio-molecular interactions In general what one wants to study in bio-molecular interactions is the specific binding of one bio-molecular to another molecule (which may or may not be a bio-molecule). Any interaction which binds a molecule to the surface generates a signal. That is, the biochip readout instrument cannot generally distinguish between a specific binding event (between target and receptor, which is what the researcher wants to study) and between target and surface. A proper biochip surface coverage must minimize this later interaction.
  • Porous silicon contains pores which in the preferred embodiment have an aspect ratio in the range of 30-80 and have pore diameters near 80 nm.
  • the solution phase methods taught in for example US Patent 5,436,161 would not successfully coat the insides of these pores.
  • the as prepared poSi material is quite hydrophobic and is not amenable to thorough wetting by aqueous solutions.
  • the as prepared material is not stable to typical buffering conditions as the thin walls of the material are readily dissolved by solutions near neutral pH.
  • material which reacts well with silica tends to also be susceptible to polymerization. This polymerization can easily clog the pores of the material and render it useless for label free biding studies.
  • silica is then protected with a silane (FIGlA-B) which generally leaves a hydrophic surface not easily reacted with acqueous reagents. This surface is then rendered hydrophilic (FIG IA-C) through where a number of molecules could be used.
  • Porous silicon biochips are formed by anodic etching in HF acid solution as described previously in the parent applications cited in the first paragraph of this specification which are incorporated herein by reference. This etching process leaves a surface where the silicon bonds are terminated with hydrogen as shown at A in FIG. IA.
  • This Si-H surface may be converted to a silica surface as shown at B in FIG. 1 (A 5 E & H) by a variety of means including baking in an oxygenated atmosphere at 200° C, O 2 plasma cleaning, or soaking in water (with or without heat). Applicants' preferred technique is the baking process, though other processes are possible.
  • the Si-O " surface is then silanized by coating it with a silane which protects the porous silicon surface from degradation as well as allows further reactions to take place.
  • the proper method for silanizing the porous silicon surface must account for the high aspect ratio of the pores, which in the preferred embodiment ranges from 30-80. To accomplish this, a multi-step process is preferred which is designed to completely coat the pore surface, while avoiding self polymerization of the silane reagent.
  • a tri-alkoxy silane e.g. 3-glycidoxypropyl tri-methoxy silane - GOPTS see FIG. 2
  • MMD molecular vapor phase deposition
  • an amount of GOPTS is introduced which is not enough to cover the entire surface.
  • FIG. 3 The GOPTS molecule has four reactive moieties and care needs to be taken to avod polymerizing the material.
  • step C of FIG IA is performed.
  • an epoxide group of the GOPTS is used to react one of a variety of 'intermediate' moieties whose purpose is to minimize non-specific binding and allow for easy immobilization of receptors.
  • the preferred embodiment makes use of a polymer 'cut' from a polyethylene glycol reaction as indicated in FIG. IB(G).
  • PEG molecules of a variety of lengths are used with the mean PEG length (see n in FIG. 5) varied between 4-60 monomers.
  • PEGs may be applied in a variety of ways to the silanized surface (see FIG. 6).
  • the PEG molecules may be directly placed on the surface and then melted at high temperature (75- 125°C).
  • the PEG molecules may be dissolved in an organic solvent such as di-methyl formamide (DMF) and spin cast on the wafer. The solvent is then removed by evaporation and the PEG reacts again with heat (75° C).
  • the applicant preferred embodiment is to use heat.
  • the PEG 'cuts' (PEG V , or variegated length PEGs) used in this implementation have a distribution of molecular weights. Indeed it is this fact which is crucial to minimizing the non-specific binding on the biosensor chip.
  • the process leaves a carboxyl surface which can be used for immobilizing biomolecules through several R groups as shown at D in FIG. IB.
  • biomolecules to carboxyl groups
  • direct linking with primary amines through succinimide ester of the carboxyl group
  • cross linking schemes e.g. hydrazone functionalization of the carboxyl reacting with an aldehyde crosslinker on the biomolecules see e.g. US 6,800,728 which is incorporated herein by reference see FIG. 1C. scheme 2.
  • a hydrazone crosslinking scheme a different hetero-bifunctional PEG would be used to react with the epoxide.
  • the applicant's preferred embodiment is to use a 24 monomer length PEG which is synthesized in its dimeric form (FIG. 8).
  • the disulfide is reduced with a slight excess of Tris(2-carboxyethyl) phosphine (hydrochloride) (TCEP) to give two of the free thiols. These thiols (FIG. 1-J) are reacted as the other hetero-bifunctional PEGs (FIG 1-G).
  • the exposed benzaldehyde surface then reacts with molecules containing hydrazines to form a hydrazone bond, though other known reactants to aldehydes may also be used.
  • FIG 9A A protein is dissolved in 0.5 mL of water then equilibrated into phosphate buffered saline (PBS) buffer, pH 7.2, using ZEBA columns. 1 equivalent succinimidyl 6- hydrazinonicotinate acetone hydrazone (S-HyNic, SoluLink incorporation San Diego, CA) is dissolved in 0.03 mL anhydrous DMF. After complete solubilization of the S- HyNic reagent, 15 ⁇ L of the solution is added to the dissolved protein, followed by immediate rapid vortexing.
  • PBS phosphate buffered saline
  • S-HyNic succinimidyl 6- hydrazinonicotinate acetone hydrazone

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
PCT/US2008/009214 2007-07-30 2008-07-30 Method of chemical treatment of porous silicon surfaces WO2009048494A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08794883A EP2185480A4 (de) 2007-07-30 2008-07-30 Verfahren zur chemischen behandlung von porösen siliciumoberflächen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96265207P 2007-07-30 2007-07-30
US96264407P 2007-07-30 2007-07-30
US60/962,644 2007-07-30
US60/962,652 2007-07-30

Publications (1)

Publication Number Publication Date
WO2009048494A1 true WO2009048494A1 (en) 2009-04-16

Family

ID=40549450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/009214 WO2009048494A1 (en) 2007-07-30 2008-07-30 Method of chemical treatment of porous silicon surfaces

Country Status (2)

Country Link
EP (1) EP2185480A4 (de)
WO (1) WO2009048494A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10564107B2 (en) 2005-04-25 2020-02-18 Trustees Of Boston University Structured substrates for optical surface profiling
US10928315B1 (en) 2015-09-22 2021-02-23 Trustees Of Boston University Multiplexed phenotyping of nanovesicles
US11262359B2 (en) 2016-02-05 2022-03-01 NanoView Biosciences, Inc. Detection of exosomes having surface markers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800728B2 (en) * 2000-03-22 2004-10-05 Solulink Biosciences, Inc. Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US20040259094A1 (en) * 2001-09-26 2004-12-23 Raj Odedra Method of attachment of a biomolecule to a solid surface
US20060153839A1 (en) * 2002-09-16 2006-07-13 Elusys Therapeutics, Inc. Production of bispecific molecules using polyethylene glycol linkers
US7226733B2 (en) * 2001-02-21 2007-06-05 University Of Rochester Microcavity biosensor and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800728B2 (en) * 2000-03-22 2004-10-05 Solulink Biosciences, Inc. Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US7226733B2 (en) * 2001-02-21 2007-06-05 University Of Rochester Microcavity biosensor and uses thereof
US20040259094A1 (en) * 2001-09-26 2004-12-23 Raj Odedra Method of attachment of a biomolecule to a solid surface
US20060153839A1 (en) * 2002-09-16 2006-07-13 Elusys Therapeutics, Inc. Production of bispecific molecules using polyethylene glycol linkers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2185480A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10564107B2 (en) 2005-04-25 2020-02-18 Trustees Of Boston University Structured substrates for optical surface profiling
US11275030B2 (en) 2005-04-25 2022-03-15 Trustees Of Boston University Structured substrates for optical surface profiling
US10928315B1 (en) 2015-09-22 2021-02-23 Trustees Of Boston University Multiplexed phenotyping of nanovesicles
US11573177B2 (en) 2015-09-22 2023-02-07 Trustees Of Boston University Multiplexed phenotyping of nanovesicles
US11262359B2 (en) 2016-02-05 2022-03-01 NanoView Biosciences, Inc. Detection of exosomes having surface markers

Also Published As

Publication number Publication date
EP2185480A4 (de) 2010-09-08
EP2185480A1 (de) 2010-05-19

Similar Documents

Publication Publication Date Title
US7396676B2 (en) Evanescent wave sensor with attached ligand
US7193711B2 (en) Imaging method and apparatus
US5851840A (en) Biotinsilane compounds and a binding matrix containing these compounds
US7033542B2 (en) High throughput screening with parallel vibrational spectroscopy
US5492840A (en) Surface plasmon resonance sensor unit and its use in biosensor systems
US20050214167A1 (en) High throughput screening with parallel vibrational spectroscopy
JP5588430B2 (ja) 標識独立検出のための表面及びその方法
EP1780546A1 (de) Evaneszenten Wellen Sensor
US20060223113A1 (en) Immobilization of binding agents
WO2005046859A2 (en) System and method for carrying out multiple binding reactions in an array format
EP1724584A1 (de) Evaneszenzwellenmesser mit angehängtem Ligand
US11448580B2 (en) Biodetector based on interference effect of thin film with ordered porous nanostructures and method for using same to detect biomolecules
WO2012045325A1 (en) Surface plasmon resonance measuring system and a method for surface plasmon resonance measurement
Hiep et al. A microfluidic chip based on localized surface plasmon resonance for real-time monitoring of antigen–antibody reactions
US20090036327A1 (en) Method for chemical treatment of porous silicon surface
Liu et al. Rapid and regenerable surface plasmon resonance determinations of biomarker concentration and biomolecular interaction based on tris-nitrilotriacetic acid chips
EP2185480A1 (de) Verfahren zur chemischen behandlung von porösen siliciumoberflächen
WO2005106472A1 (ja) バイオチップの製造方法、バイオチップ、バイオチップ解析装置、バイオチップ解析方法
US7563587B2 (en) Method and kit for cell analyte assay
Gajos et al. Covalent and Non-covalent In-Flow Biofunctionalization for Capture Assays on Silicon Chips: White Light Reflectance Spectroscopy Immunosensor Combined with TOF-SIMS Resolves Immobilization Stability and Binding Stoichiometry
KR20100067016A (ko) 바이오 물질 검출 장치 및 이를 이용한 바이오 물질 검출 방법
Ivarsson et al. Surface plasmon resonance: development and use of BIACORE instruments for biomolecular interaction analysis
WO2004038415A1 (en) Assay with co-immobilized ligands
JP4457107B2 (ja) 固定化方法およびそのためのキット
US20040241724A1 (en) Immobilization method and kit therefor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08794883

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008794883

Country of ref document: EP